0001209191-11-039773.txt : 20110718
0001209191-11-039773.hdr.sgml : 20110718
20110718165255
ACCESSION NUMBER: 0001209191-11-039773
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20110715
FILED AS OF DATE: 20110718
DATE AS OF CHANGE: 20110718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powell Andrew Kenneth William
CENTRAL INDEX KEY: 0001304113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50767
FILM NUMBER: 11972837
MAIL ADDRESS:
STREET 1: C/O COLLAGENEX PHARMACEUTICALS, INC.
STREET 2: 41 UNIVERSITY DRIVE
CITY: NEWTOWN
STATE: PA
ZIP: 18940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORNERSTONE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001145404
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043523569
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1255 CRESCENT GREEN DRIVE
STREET 2: SUITE 250
CITY: CARY
STATE: NC
ZIP: 27518
BUSINESS PHONE: 919-678-6611
MAIL ADDRESS:
STREET 1: 1255 CRESCENT GREEN DRIVE
STREET 2: SUITE 250
CITY: CARY
STATE: NC
ZIP: 27518
FORMER COMPANY:
FORMER CONFORMED NAME: CRITICAL THERAPEUTICS INC
DATE OF NAME CHANGE: 20010719
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-07-15
0
0001145404
CORNERSTONE THERAPEUTICS INC
CRTX
0001304113
Powell Andrew Kenneth William
C/O CORNERSTONE THERAPEUTICS
1255 CRESCENT GREEN DRIVE, SUITE 250
CARY
NC
27518
0
1
0
0
EVP, General Counsel
Common Stock
2011-07-15
4
S
0
2000
8.63
D
98100
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.54 to $8.81, inclusive. The reporting person undertakes to provide to Cornerstone Therapeutics Inc., any security holder of Cornerstone Therapeutics Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
/s/ Andrew K. W. Powell
2011-07-18
EX-24.4_386245
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned, who is an officer and/or
director of Cornerstone Therapeutics Inc. (the "Company"), hereby makes,
constitutes and appoints Craig A. Collard, Vincent Morgus, and Amy Diebler, and
each of them singly, as the undersigned's true and lawful attorneys in fact with
full power and authority as hereinafter described to:
1. execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of the Company, Forms 3, 4, and 5 (including any
amendments thereto) in accordance with Section 16(a) of the Securities Exchange
Act of 1934 and the rules thereunder (the "Exchange Act") with respect to
securities of the Company beneficially owned by the undersigned;
2. do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to prepare, complete and execute any such Form 3,
4, or 5, prepare, complete and execute any amendment or amendments thereto, and
timely deliver and file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority, including, but not
limited to, executing a Form ID for and on behalf of the undersigned and filing
such Form ID with the United States Securities and Exchange Commission;
3. seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information regarding transactions in the Company's securities from any
third party, including brokers, employee benefit plan administrators and
trustees, and the undersigned hereby authorizes any such person to release any
such information to such attorney and approves and ratifies any such release of
information; and
4. take any other action of any type whatsoever in connection with the foregoing
which, in the opinion of such attorney, may be of benefit to, in the best
interest of, or legally required by, the undersigned, it being understood that
the documents executed by such attorney on behalf of the undersigned pursuant to
this Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney may approve in such attorney's discretion.
The undersigned hereby grants to each attorney in fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary,
or proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney, or such attorney's substitute
or substitutes, shall lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneys, in serving in such capacity at the request of the
undersigned, are not assuming nor relieving, nor is the Company assuming nor
relieving, any of the undersigned's responsibilities to comply with Section 16
of the Exchange Act. The undersigned acknowledges that each of the Company and
the foregoing attorneys in fact do not assume (i) any liability for the
undersigned's responsibility to comply with the requirements of the Exchange
Act, (ii) any liability of the undersigned for any failure to comply with such
requirements, or (iii) any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
of (i) the date and time that the undersigned is no longer required to file
Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions
in securities issued by the Company, or (ii) the date and time that this Power
of Attorney is revoked by the undersigned in a signed writing delivered to the
foregoing attorneys in fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 17th day of May, 2011.
By: /s/ Andrew K. W. Powell
Print Name: Andrew K. W. Powell